Aarti Drugs shares jumped more than 2% in morning trade after its subsidiary, Pinnacle Life Science Private Limited, got a “Certificate of GMP Compliance of a Manufacturer” from the Medicines and Healthcare products Regulatory Agency (UK MHRA) for its manufacturing facility located in Baddi, Himachal Pradesh.
The company highlighted that there have been no violations or breaches and that the certification has no current financial or major impacts on the company.
As of 10:37 am, Aarti Drugs shares were trading 2.47% higher at Rs 526.90 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
